Dr. Stefano Ravalli, MD

Dr. Ravalli practices at Columbia University Irving Medical Center in New York, New York.

Dr. Ravalli's NPI, 1174600126, was assigned on November 1, 2006. Dr. Ravalli graduated from Sapienza University of Rome in 1986. Dr. Ravalli holds New York license 209832.

Dr. Ravalli's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Ravalli's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Ravalli is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Ravalli to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ravalli practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Ravalli's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Ravalli is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Ravalli's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists atherosclerosis, congestive heart failure, coronary artery disease, heart attack, heart failure and heart valve disorders among the conditions Dr. Ravalli treats.

CMS data shows 1,096 Medicare services from Dr. Ravalli across 9 procedure codes in 2024, for 748 Medicare patients. Medicare paid $120,861 for them.

CMS counts 748 Medicare patients who saw Dr. Ravalli in 2024. The largest group is 65 to 74, with 283 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ravalli's median patient age at 72, with 40% women.

In 2024, Dr. Ravalli wrote 18 Medicare Part D claims. 100% of them were for generic drugs. They cover 13 drugs, with $88,872 in total drug cost. In 2021, CMS named 2,525 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ravalli for performance year 2024, reported through an alternative payment model (APM). Dr. Ravalli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Ravalli, published from 2020 to 2023. The most frequent topics are Arteriosclerosis. Dr. Ravalli has published most often in CASE (Phila). Dr. Ravalli's most frequent co-authors are Elena Dudorova, MD, Walif Aji, MD and Benjamin Navot, MD.

CMS Open Payments shows 1 general payment to Dr. Ravalli from 1 drug or device company in 2020. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $14.

Dmand AI lists 3 awards for Dr. Ravalli, most recently Super Doc in 2012.

Dr. Ravalli graduated from Sapienza University of Rome in 1986. Dr. Ravalli is a member of ACC, AHA and European Society of Cardiology.

Dr. Ravalli is in network with 10 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.